Literature DB >> 1558293

Disulfiram treatment of patients with both alcohol dependence and other psychiatric disorders: a review.

E W Larson1, A Olincy, T A Rummans, R M Morse.   

Abstract

In treatment of alcohol dependence, disulfiram is most useful in conjunction with a structured, supervised, aftercare program. However, it has been reported to cause psychiatric side effects and to interact with various psychiatric medications. Many patients with alcohol dependence suffer from other psychiatric disorders and are treated with such psychiatric medications. This paper reviews the pertinent clinical pharmacology of disulfiram and the literature on potential psychiatric complications and drug interactions of disulfiram. At the usual dosage, about 250 mg/day, disulfiram does not appear to increase significantly the risk of psychiatric complications or of psychiatric drug interactions. Therefore, it can be considered a treatment option for patients with alcohol dependence and other psychiatric disorders.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1558293     DOI: 10.1111/j.1530-0277.1992.tb00648.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  8 in total

1.  Psychotic spectrum disorders and alcohol abuse: a review of pharmacotherapeutic strategies and a report on the effectiveness of naltrexone and disulfiram.

Authors:  Ismene L Petrakis; Charla Nich; Elizabeth Ralevski
Journal:  Schizophr Bull       Date:  2006-08-03       Impact factor: 9.306

2.  Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.

Authors:  Lakshmi N Yatham; Sidney H Kennedy; Sagar V Parikh; Ayal Schaffer; David J Bond; Benicio N Frey; Verinder Sharma; Benjamin I Goldstein; Soham Rej; Serge Beaulieu; Martin Alda; Glenda MacQueen; Roumen V Milev; Arun Ravindran; Claire O'Donovan; Diane McIntosh; Raymond W Lam; Gustavo Vazquez; Flavio Kapczinski; Roger S McIntyre; Jan Kozicky; Shigenobu Kanba; Beny Lafer; Trisha Suppes; Joseph R Calabrese; Eduard Vieta; Gin Malhi; Robert M Post; Michael Berk
Journal:  Bipolar Disord       Date:  2018-03-14       Impact factor: 6.744

Review 3.  Safety issues concerning the use of disulfiram in treating alcohol dependence.

Authors:  J Chick
Journal:  Drug Saf       Date:  1999-05       Impact factor: 5.606

Review 4.  Substance misuse in patients with schizophrenia: epidemiology and management.

Authors:  David J Kavanagh; John McGrath; John B Saunders; Glenys Dore; Dianne Clark
Journal:  Drugs       Date:  2002       Impact factor: 9.546

5.  CURRENT STATUS OF DISULFIRAM THERAPY.

Authors:  P K Chakraborty; H Singh; K J Divinakumar
Journal:  Med J Armed Forces India       Date:  2011-07-21

Review 6.  Safety and Tolerability of Pharmacological Treatment of Alcohol Dependence: Comprehensive Review of Evidence.

Authors:  Julia M A Sinclair; Sophia E Chambers; Celia J Shiles; David S Baldwin
Journal:  Drug Saf       Date:  2016-07       Impact factor: 5.606

7.  Disulfiram Induced Psychosis.

Authors:  Satyakam Mohapatra; Nihar Ranjan Rath
Journal:  Clin Psychopharmacol Neurosci       Date:  2017-02-28       Impact factor: 2.582

8.  Anxiety and alcohol use disorders: comorbidity and treatment considerations.

Authors:  Joshua P Smith; Carrie L Randall
Journal:  Alcohol Res       Date:  2012
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.